Liraglutide as add-on to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes: a 26-week, randomised, double-blind, placebo-controlled trial Article

Web of Science: 000485303803098
Industry Collaboration International Collaboration

Cited authors

  • Rea, R.; Blonde, L.; Belousova, L.; Fainberg, U.; Garcia-Hernandez, P. A.; Jain, S. M.; Kaltoft, M. S.; Mosenzon, O.; Nafach, J.; Palle, M. S.

Authors

Publication date

  • 2019

Published in

International Standard Serial Number (ISSN)

  • 0012-186X

Start page

  • S371

End page

  • S372

Volume

  • 62